EUVIMEDDescoperă EUVIMED
Crossref

Mechanism-Informed Dermatology: Translational Advances in Immune-Mediated Inflammatory Skin Diseases

Genaro Escobar Cruz, Karla Leslie Martínez Hernández, Nicole Vanessa Larrea Ortiz, José Arnulfo Perez Carrillo, Nancy Fabiola Diaz Martinez, Wilmer Rene Cujilema Guillin, Diana Flores Rios, Darime Galatea Orduña Mérida

IECCMEXICO · 2026-03-02 · 4 (3)

DOI: 10.64784/150 ↗

At a glance

Journal article in IECCMEXICO, published online on 2026-03-02. Written by Genaro Escobar Cruz and 7 co-authors.

RezumatDate bibliograficeCiteRelated studies

Abstract (original language)

Immunologic and inflammatory skin disorders have undergone a profound conceptual transformation over the past two decades. Conditions such as psoriasis, atopic dermatitis, autoimmune blistering diseases, and cutaneous lupus erythematosus are now understood as immune-mediated entities driven by specific pathogenic pathways rather than solely morphologic diagnoses. This review synthesizes contemporary high-impact literature to analyze emerging diagnostic and therapeutic paradigms, emphasizing the transition from broad immunosuppression to mechanism-informed precision targeting. Particular attention is given to the IL-23/Th17 axis in psoriasis, type 2 inflammation in atopic dermatitis, and autoantibody-mediated mechanisms in blistering disorders. The review further compares cytokine-specific biologics with intracellular pathway modulators such as JAK inhibitors, highlighting distinctions in monitoring requirements, breadth of immunologic impact, and practical considerations. A structured therapeutic sequencing model is proposed, integrating clinical severity, immunologic alignment, safety monitoring, and healthcare feasibility. Special consideration is given to implementation in diverse international contexts, including Mexico, Colombia, and Ecuador. The findings support a unified framework in which diagnosis remains clinically grounded but conceptually reinforced by immunopathogenesis, and treatment selection is increasingly guided by targeted immune modulation. This paradigm reflects the broader evolution of translational medicine and underscores the necessity of adaptable, evidence-based strategies in inflammatory dermatology.

Cite

APA

Cruz, G. E., Hernández, K. L. M., Ortiz, N. V. L., Carrillo, J. A. P., Martinez, N. F. D., Guillin, W. R. C., Rios, D. F., & Mérida, D. G. O. (2026). Mechanism-Informed Dermatology: Translational Advances in Immune-Mediated Inflammatory Skin Diseases. IECCMEXICO, 4(3). https://doi.org/10.64784/150

Vancouver

Cruz GE, Hernández KLM, Ortiz NVL, Carrillo JAP, Martinez NFD, Guillin WRC, et al. Mechanism-Informed Dermatology: Translational Advances in Immune-Mediated Inflammatory Skin Diseases. IECCMEXICO. 2026;4(3). doi:10.64784/150

BibTeX
@article{Cruz2026,
  author = {Cruz, Genaro Escobar and Hernández, Karla Leslie Martínez and Ortiz, Nicole Vanessa Larrea and Carrillo, José Arnulfo Perez and Martinez, Nancy Fabiola Diaz and Guillin, Wilmer Rene Cujilema and Rios, Diana Flores and Mérida, Darime Galatea Orduña},
  title = {Mechanism-Informed Dermatology: Translational Advances in Immune-Mediated Inflammatory Skin Diseases},
  journal = {IECCMEXICO},
  year = {2026},
  volume = {4},
  number = {3},
  doi = {10.64784/150}
}
Start for free →